Showing results (221-230 of 372) with videos related to
Sort By:
Pageof 38
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 28, 2002
Totally endoscopic bilateral internal thoracic artery bypass grafting in a young diabetic patientSelami Dogan, Tayfun Aybek, Mohammed F Khan, et al.Annals of the Rheumatic Diseases|September 4, 2004
Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix proteinM Neidhart, F Zaucke, R von Knoch, et al.Cancer Research|September 1, 1984
Interferon-alpha therapy of renal cancerJ A Neidhart, M M Gagen, D Young, et al.Oncotargets and Therapy|December 13, 2016
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancerEdward B Garon, Jeffrey D Neidhart, Nashat Y Gabrail, et al.Science (New York, N.Y.)|February 3, 2022
Diversification of aliphatic C-H bonds in small molecules and polyolefins through radical chain transferTimothy J Fazekas, Jill W Alty, Eliza K Neidhart, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
GM-CSF, carboplatin, doxorubicin: a phase I studyE A Poplin, D S Alberts, J J Rinehart, et al.Kidney International|September 1, 1996
GM-CSF secretion in primary cultures of normal and cancerous human renal cellsN D Stephens, S L Barton, A Y Smith, et al.Journal of Biological Response Modifiers|June 1, 1988
Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1)J A Neidhart, S Schmidt, M Rosenblum, et al.Nutrition and Cancer|January 1, 1987
Weight change and peptide hormone responses in patients receiving interferonR S Hurley, T M O'Dorisio, B M Bossetti, et al.Investigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.Pageof 38